Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06060197Completed
MCT8 Deficiency Caregiver Study
Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency
PrincipalinvestigatorStart date: 2022-08-23

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Andrew J. Bauer, MD

Children's Hospital of Philadelphia

Moderately Similar
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Rare Thyroid Therapeutics International AB
Similarity Score30%

Andrew Bauer, MD

Children's Hospital of Philadelphia

Moderately Similar
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Rare Thyroid Therapeutics International AB
Similarity Score30%

Heiko Krude

Charité - Universitätsmedizin Berlin Institut fur experimental paediatrische endokrinologie

Moderately Similar
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Rare Thyroid Therapeutics International AB
Similarity Score30%

W. E. Visser, MD

Erasmus Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Rare Thyroid Therapeutics International AB
Similarity Score30%

W.E. Visser, MD, PhD

Erasmus Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Rare Thyroid Therapeutics International AB
Similarity Score30%

Lindsey Nicol

Oregon Health& Science University (OHSU) Doernbecher Childrens Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Rare Thyroid Therapeutics International AB
Similarity Score30%

Kristina Sjöblom Nygren, MD

Rare Thyroid Therapeutics International AB

Moderately Similar
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Rare Thyroid Therapeutics International AB
Similarity Score30%

Jan Lebl

Charles University and Motol University Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Rare Thyroid Therapeutics International AB
Similarity Score30%

Heiko Krude, MD

Charite University, Berlin, Germany

Related
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley Syndrome
Similarity Score15%

W.E. Visser, dr,

Erasmus Medical Center

Related
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley Syndrome
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06060197PrincipalInvestigator

MCT8 Deficiency Caregiver Study

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency
Completed

All 1 trials loaded